GH1 and Alzheimer disease: Given the importance of the GH/IGF-1 axis as a potential therapeutic target, further interrogation of this pathway, and its temporal and spatial role in metabolic health and AD pathogenesis, particularly with newly-developed AD strains, is warranted.